Treatment-Resistant Depression in Utah (Ages 12+)
When Depression Persists
Treatment-resistant depression commonly refers to depression that has not improved sufficiently after at least two adequate antidepressant trials. Persistent symptoms, relapse or difficult side effects can warrant a fresh review even before that threshold is reached.
You do not need to wait for multiple treatments to fail before asking about your options. A psychiatric evaluation can help clarify next steps, including therapy, medication care or advanced treatment.
Review Your Options Sooner
If treatment is not helping enough, we review what has been tried, how it was tolerated and what may be contributing to continuing symptoms. Depending on your needs and preferences, next steps may include medication changes, psychotherapy or an assessment for advanced treatment. The right timing and approach are individualized.
When to Reassess Your Depression Treatment
-
Persistent depressive symptoms despite treatment
-
Partial improvement followed by relapse
-
Intolerable medication side effects
-
Chronic low mood lasting years (Persistent Depressive Disorder)
-
Functional impairment despite ongoing care
Our Approach to Treatment-Resistant Depression
You can start with a psychiatric evaluation for broader assessment and medication-management planning, or contact us directly about TMS or ketamine care. Advanced treatment requires its own medical and psychiatric suitability review. Self-pay access and insurance requirements are separate; coverage depends on your plan and its criteria.
We Assess:
Treatment planning may include:
Advanced Treatment Options Available in Lehi
Coordinated Care Model
Telehealth and In-Person Services
Safety and Clinical Oversight
​We review prior medication and therapy history, co-occurring conditions, trauma exposure, sleep and lifestyle factors, and biological and psychological contributors.
-
Adjustment of medication strategy
-
Depth-oriented therapy
-
Advanced brain-based interventions
For appropriate candidates, we offer Transcranial Magnetic Stimulation (TMS) and IV or IM Ketamine Therapy in-office at our Lehi location.
Ketamine is administered in a monitored medical setting. Its use for depression is off-label; benefits, risks and suitability are reviewed individually. We do not provide Spravato (esketamine nasal spray).
TMS coverage depends on your insurance plan and its criteria. Self-pay TMS access is considered separately from insurance requirements and still requires treatment-specific screening. Other advanced applications may be offered on a private-pay basis.
Treatment-resistant depression often benefits from integrated care. Depending on individual needs, care may include therapy, medication management, TMS or IV or IM ketamine.
Therapy is generally required as part of ketamine care and may be provided in-house or by your existing outside therapist.
Psychiatric evaluations and therapy may be available by telehealth in Utah when appropriate. TMS and IV or IM ketamine are provided in person in Lehi.
General psychiatric care is available for ages 12 and older. Eligibility for a particular advanced treatment depends on age, clinical needs and treatment-specific criteria.
Contact us to discuss next steps.
All advanced treatments are delivered within a structured medical setting. Patients are evaluated for medical and psychiatric suitability before beginning TMS or IV or IM ketamine. Treatment recommendations and monitoring are individualized.
Do I need to try multiple medications before contacting you?
No. You can ask about options at any stage. A clinician will review your history and determine which treatments are appropriate. Insurance coverage for TMS may require documented prior treatment trials; self-pay access is considered separately and does not replace treatment-specific screening.